Health score, price, valuation, risk signals, and key metrics at a glance.
Strongest: Growth (17.5/25); weakest: Cash & Earnings Quality (2/25).
Data-driven signals worth keeping an eye on across the last 8 quarters
Free cash flow has been negative in 8 of the last 8 quarters — earnings are not translating to cash.
D/E ratio of 2.4 is elevated and rising. Watch for further debt accumulation.
as of August 2026
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
The last 8 consecutive quarters had negative FCF — the company is burning cash and may need external funding.